Companies: 10,795·Total market cap: $144.5T
Impel Pharmaceuticals Inc.

Impel Pharmaceuticals Inc.

IMPLNASDAQHealthcare
$0.04
$-0.02(-27.27%)
Market Cap$956000
P/E Ratio
52W High$4.2
52W Low$0.0212
Overview

Impel Pharmaceuticals Inc. (IMPL) · Balance Sheet

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · IMPL · as of 2026-06-09

Financial statements

Total Assets · Total Liabilities · Equity
Breakdown2022-122021-122020-122019-12
Assets
Cash & ST Investments$60.65M$88.21M$7.09M$37.00M
Net Receivables$7.44M$1.35M$0.00M$0.00M
Inventory$8.43M$2.82M$0.00M$0.00M
Total Current Assets$79.81M$94.58M$8.17M$39.52M
PP&E Net$7.00M$3.15M$3.70M$2.74M
Goodwill$0.00M$0.00M$0.00M$0.00M
Intangible Assets$0.00M$0.00M$0.00M$0.00M
Total Assets$88.55M$97.91M$12.06M$42.27M
Liabilities
Short-Term Debt$1.54M$0.00M$0.42M$0.00M
Accounts Payable$6.09M$6.37M$4.31M$2.73M
Total Current Liabilities$22.16M$15.95M$10.53M$8.32M
Long-Term Debt$49.65M$29.45M$7.99M$0.00M
Total Liabilities$132.71M$45.40M$145.56M$133.97M
Stockholders Equity
Retained Earnings($321.11M)($214.80M)($138.26M)($92.46M)
Total Stockholders Equity($44.16M)$52.51M($133.50M)($91.70M)
Total Liab & Equity(computed)$88.55M$97.91M$12.06M$42.27M
Debt Summary
Total Debt$51.19M$29.45M$8.41M$0.00M
Net Debt($9.47M)($58.76M)$1.32M($37.00M)

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M

Explore more Impel Pharmaceuticals Inc. data

About Impel Pharmaceuticals Inc. (IMPL) Balance Sheet

Impel Pharmaceuticals Inc. (IMPL) balance sheet shows total assets of $0.09B with cash of $0.06B. Total liabilities are $0.13B, total debt $0.05B, and stockholders equity ($0.04B).

Frequently asked questions

IMPL · 4 questions

Impel Pharmaceuticals Inc. has total debt of $0.05B with net debt of ($0.01B).

IMPL total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09